Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy
Barium ferrite nanoparticles (BaFeNPs) were investigated as vehicles for <sup>223</sup>Ra radionuclide in targeted α-therapy. BaFe nanoparticles were labeled using a hydrothermal Ba<sup>2+</sup> cations replacement by <sup>223</sup>Ra with yield reaching 61.3 ± 1....
Main Authors: | Weronika Gawęda, Marek Pruszyński, Edyta Cędrowska, Magdalena Rodak, Agnieszka Majkowska-Pilip, Damian Gaweł, Frank Bruchertseifer, Alfred Morgenstern, Aleksander Bilewicz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/10/10/2067 |
Similar Items
-
Radium 223 dichloride for prostate cancer treatment
by: Deshayes E, et al.
Published: (2017-09-01) -
Association between the Immunophenotype of Peripheral Blood from mCRPC Patients and the Outcomes of Radium-223 Treatment
by: Elisabet Cantó, et al.
Published: (2023-06-01) -
Feasibility study of radium-223 production in Tehran Research Reactor for treatment of bone metastases
by: Reza Bagheri, et al.
Published: (2016-02-01) -
Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
by: Monica Vidal, et al. -
POSSIBILITIES OF RADIUM-223 APPLICATION IN THERAPY OF PROSTATE GLAND CANCER
by: A. A. GRITSKEVICH, et al.
Published: (2017-06-01)